Lopaschuk G - Search Results

1

Winter S, Buist NR, Longo N, Armenian SH, Lopaschuk G, Wasilewska A. Winter S, et al. Among authors: lopaschuk g. Ann Nutr Metab. 2016;68 Suppl 3:21-23. doi: 10.1159/000448323. Epub 2016 Dec 9. Ann Nutr Metab. 2016. PMID: 27931031 Free article.

2

Fatty Acid Oxidation and Its Relation with Insulin Resistance and Associated Disorders.

Lopaschuk GD. Lopaschuk GD. Ann Nutr Metab. 2016;68 Suppl 3:15-20. doi: 10.1159/000448357. Epub 2016 Dec 9. Ann Nutr Metab. 2016. PMID: 27931032 Free article. Review.

3

Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance.

Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, Ilkayeva O, Bain J, Stevens R, Dyck JR, Newgard CB, Lopaschuk GD, Muoio DM. Koves TR, et al. Cell Metab. 2008 Jan;7(1):45-56. doi: 10.1016/j.cmet.2007.10.013. Cell Metab. 2008. PMID: 18177724 Free article.

4

Therapeutic effects of adropin on glucose tolerance and substrate utilization in diet-induced obese mice with insulin resistance.

Gao S, McMillan RP, Zhu Q, Lopaschuk GD, Hulver MW, Butler AA. Gao S, et al. Mol Metab. 2015 Jan 17;4(4):310-24. doi: 10.1016/j.molmet.2015.01.005. eCollection 2015 Apr. Mol Metab. 2015. PMID: 25830094 Free PMC article.

5

Role of fatty acid uptake and fatty acid beta-oxidation in mediating insulin resistance in heart and skeletal muscle.

Zhang L, Keung W, Samokhvalov V, Wang W, Lopaschuk GD. Zhang L, et al. Biochim Biophys Acta. 2010 Jan;1801(1):1-22. doi: 10.1016/j.bbalip.2009.09.014. Epub 2009 Sep 24. Biochim Biophys Acta. 2010. PMID: 19782765 Review.

6

Cardiac fatty acid oxidation in heart failure associated with obesity and diabetes.

Fukushima A, Lopaschuk GD. Fukushima A, et al. Biochim Biophys Acta. 2016 Oct;1861(10):1525-34. doi: 10.1016/j.bbalip.2016.03.020. Epub 2016 Mar 18. Biochim Biophys Acta. 2016. PMID: 26996746 Review.

This article is part of a Special Issue entitled: Heart Lipid Metabolism edited by G.D. Lopaschuk....

7

Cardiac branched-chain amino acid oxidation is reduced during insulin resistance in the heart.

Fillmore N, Wagg CS, Zhang L, Fukushima A, Lopaschuk GD. Fillmore N, et al. Am J Physiol Endocrinol Metab. 2018 Nov 1;315(5):E1046-E1052. doi: 10.1152/ajpendo.00097.2018. Epub 2018 Aug 14. Am J Physiol Endocrinol Metab. 2018. PMID: 30106622 Free article.

8

Targets for modulation of fatty acid oxidation in the heart.

Lopaschuk GD. Lopaschuk GD. Curr Opin Investig Drugs. 2004 Mar;5(3):290-4. Curr Opin Investig Drugs. 2004. PMID: 15083595 Review.

9

Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy.

Fillmore N, Mori J, Lopaschuk GD. Fillmore N, et al. Among authors: lopaschuk gd. Br J Pharmacol. 2014 Apr;171(8):2080-90. doi: 10.1111/bph.12475. Br J Pharmacol. 2014. PMID: 24147975 Free PMC article. Review.

10

Acetylation control of cardiac fatty acid β-oxidation and energy metabolism in obesity, diabetes, and heart failure.

Fukushima A, Lopaschuk GD. Fukushima A, et al. Biochim Biophys Acta. 2016 Dec;1862(12):2211-2220. doi: 10.1016/j.bbadis.2016.07.020. Epub 2016 Jul 29. Biochim Biophys Acta. 2016. PMID: 27479696 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

441 results

Search Page